The influence of the pharmaceutical industry on the off-label use of its medicines

Journal of Medical Ethics 28 (4):277-277 (2002)
  Copy   BIBTEX

Abstract

This article has no associated abstract. (fix it)

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 91,219

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

Similar books and articles

Corporate Responsibilities for Access to Medicines.Klaus M. Leisinger - 2009 - Journal of Business Ethics 85 (S1):3 - 23.
Pharmaceutical medicine.D. M. Burley & Theodore Barker Binns (eds.) - 1985 - Baltimore, Md., U.S.A.: E. Arnold.
Big pharma: a story of success in a market economy. [REVIEW]Joao Calinas-Correia - 2013 - Medicine, Health Care and Philosophy 16 (2):305-309.
Ethics, pricing and the pharmaceutical industry.Richard A. Spinello - 1992 - Journal of Business Ethics 11 (8):617 - 626.
Big Pharma: a former insider’s view. [REVIEW]David Badcott - 2013 - Medicine, Health Care and Philosophy 16 (2):249-264.

Analytics

Added to PP
2010-08-24

Downloads
36 (#421,132)

6 months
5 (#544,079)

Historical graph of downloads
How can I increase my downloads?

Citations of this work

No citations found.

Add more citations

References found in this work

No references found.

Add more references